ArticlePloS one2026
Effect of targeted temperature management on neurological and survival outcomes in patients undergoing extracorporeal cardiopulmonary resuscitation.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTargeted temperature management (TTM) has been a fundamental component of post-resuscitation care for patients experiencing cardiac arrest for many years. This study aims to investigate the association between TTM and clinical outcomes in patients undergoing extracorporeal cardiopulmonary resuscitation (ECPR).
methodsThis retrospective cohort study was conducted at a single tertiary medical center in Taiwan. A total of 360 patients were screened between January 2015 and May 2023, with 148 excluded. After selection, 212 patients were included in the final analysis, with 79 receiving TTM and 133 not receiving TTM.
findingsPatients in the TTM group had a higher rate of successful weaning from extracorporeal membrane oxygenation (64.6% vs. 42.1%, p = 0.002), survival to discharge (58.2% vs. 38.3%, p = 0.005) and lower cerebral performance category (CPC) scores at discharge (3.6 vs. 4.2, p = 0.001). A higher proportion of patients in the TTM group had a CPC score of 1-2 points at discharge, indicative of a favorable neurologic outcome (29.1% vs. 10.5%, p < 0.001). After adjusting for potential confounders, TTM was significantly associated with reduced odds of in-hospital death (adjusted odds ratio [OR] 0.34, 95% confidence interval [CI] 0.15-0.72, p = 0.006) and poor neurological outcomes (CPC 3-5; adjusted OR 0.30, 95% CI 0.12-0.72, p = 0.008).
conclusionsAmong patients receiving ECPR, the use of TTM is associated with improved neurological outcomes and increased survival to hospital discharge. Future randomized controlled trials are needed to elucidate the pathophysiology and clinical impact of combining TTM with ECPR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.